Results
242
Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.
242 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
SRPT | US$154.20 | -2.4% | 35.9% | US$14.8b | US$197.81 | PE862.6x | E39.4% | n/a | Pharmaceuticals & Biotech | ||
NVDA | US$122.67 | -2.7% | 189.2% | US$3.1t | US$132.34 | PE70.8x | E22.7% | 0.03% | Semiconductors | ||
ARES | US$135.45 | 0.07% | 40.3% | US$42.6b | US$149.17 | PE62.7x | E29.7% | 2.7% | Diversified Financials | ||
NU | US$12.35 | -1.2% | 55.2% | US$59.1b | US$13.02 | PB8.7x | E27.9% | n/a | Banks | ||
CRWD | US$385.05 | -0.4% | 163.8% | US$95.4b | US$402.53 | PE711.7x | E34.8% | n/a | Software | ||
PDD | US$133.88 | -4.4% | 87.8% | US$184.7b | US$205.59 | PE16.9x | E23.2% | n/a | Retail | ||
SGEN | US$228.74 | 4.5% | 76.5% | US$43.2b | US$228.91 | PS18.8x | E71.8% | n/a | Pharmaceuticals & Biotech | ||
SMCI | US$837.17 | -0.7% | 235.9% | US$47.6b | US$1,032.47 | PE46.7x | E40.2% | n/a | Tech | ||
CG | US$40.01 | 0.5% | 23.6% | US$14.2b | US$48.45 | PS6.5x | E23.6% | 3.5% | Diversified Financials | ||
OWL | US$17.54 | -0.7% | 51.5% | US$25.4b | US$21.12 | PE128.4x | E88.4% | 4.1% | Diversified Financials | ||
SYM | US$36.19 | 13.9% | -17.0% | US$20.7b | US$56.64 | PS2.5x | E131.1% | n/a | Capital Goods | ||
PTC | US$182.89 | 3.3% | 30.3% | US$21.7b | US$203.05 | PE76.1x | E22.8% | n/a | Software | ||
TER | US$149.60 | 1.4% | 34.1% | US$23.1b | US$131.01 | PE54.4x | E23.8% | 0.3% | Semiconductors | ||
VRT | US$88.00 | -4.1% | 253.8% | US$32.4b | US$102.88 | PE81.5x | E30.4% | 0.1% | Capital Goods | ||
ELF | US$204.23 | -2.2% | 80.3% | US$11.4b | US$209.92 | PE89.5x | E21.1% | n/a | Household | ||
ZS | US$196.66 | 7.7% | 34.2% | US$30.0b | US$229.92 | PS14.6x | E50.9% | n/a | Software | ||
SPOT | US$315.55 | -1.8% | 96.5% | US$62.5b | US$346.34 | PS4.2x | E40.6% | n/a | Media | ||
CHK | US$83.02 | -0.7% | -0.9% | US$10.8b | US$105.03 | PE10.3x | E36.5% | 2.9% | Energy | ||
ALNY | US$247.61 | 3.1% | 30.5% | US$30.8b | US$248.46 | PS15.6x | E63.6% | n/a | Pharmaceuticals & Biotech | ||
NTNX | US$59.79 | 11.9% | 111.8% | US$14.7b | US$74.54 | PS7x | E82.8% | n/a | Software | ||
RYAN | US$57.35 | -2.8% | 28.6% | US$14.8b | US$58.08 | PE107.3x | E56.6% | 0.8% | Insurance | ||
MPWR | US$828.75 | 1.1% | 52.7% | US$39.9b | US$788.03 | PE98.4x | E20.4% | 0.6% | Semiconductors | ||
TEAM | US$182.28 | 8.9% | 8.8% | US$46.4b | US$239.60 | PS11.4x | E45.4% | n/a | Software | ||
ARM | US$163.46 | 1.8% | n/a | US$165.2b | US$119.56 | PE555.7x | E31.0% | n/a | Semiconductors |